Avantor (AVTR) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Avantor (AVTR) do?
Avantor Inc (AVTR) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures ultra-high-purity chemicals, chromatography resins, and specialized silicones for life sciences research. Supplies custom ultra-pure materials, lab consumables, and distribution services directly integrated into. It is worth $10.25B on the market and sold $6.65B over the last year.
- Market cap
- $10.25B
- P/E ratio
- 30.5×
- Annual sales
- $6.65B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 16, 2026
Brands and businesses behind AVTR
- VWR: Distributes lab equipment, consumables, and safety supplies to research institutions and commercial laboratories.
- Masterflex: Manufactures peristaltic pumps and fluid handling systems for biopharmaceutical and industrial processes.
- J.T.Baker: Produces high-purity chemicals and reagents used in pharmaceutical manufacturing and semiconductor production.
- NuSil: Formulates high-purity medical silicone materials used in implantable devices and aerospace systems.
- Macron Fine Chemicals: Provides high-grade salts, acids, and solvents for analytical testing and pharmaceutical formulation.
AVTR’s flags, in plain English
Each flag is a number from Avantor’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.
Stupid Cash
Can pay this year's bills 1.9 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Priced for Perfection
The price is running well ahead of the growth. The share price already assumes strong results, so news that is merely good can still send it down.
1 more risk note open with the free trial. Try it free for 7 days.
Questions about AVTR
How big is Avantor?
Avantor’s market cap is $10.25B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $6.65B: what customers paid the company over the last year, before any costs.
What is AVTR’s P/E ratio?
AVTR’s P/E ratio is 30.5×. Investors pay about 30.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with AVTR?
The company carries over five billion dollars in net debt from past corporate acquisitions. That is one risk on Avantor’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Avantor’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. AVTR’s filings on SEC.gov. The Margin Monkey is research, not advice.
